Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Views 900
Citations 0
Comment & Response
February 3, 2015

Proposed Shift in Screening for Breast Cancer—Reply

Author Affiliations
  • 1Department of Medicine, University of Washington, Seattle
  • 2Faculty of Medicine, Hebrew University Medical School, Jerusalem, Israel
  • 3Medical Genetics Institute, Shaare Zedek Medical Center, Jerusalem, Israel

Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA. 2015;313(5):525-526. doi:10.1001/jama.2014.17442

In Reply Drs Levine and Steinberg are concerned about the number of women to be screened and the risks and costs of population-based screening for mutations in BRCA1 and BRCA2. It is accepted that a healthy woman with severe family history of breast or ovarian cancer should be offered testing for actionable mutations in BRCA1 and BRCA2 because cancer risk to mutation carriers can be significantly reduced by surgical intervention.1,2

First Page Preview View Large
First page PDF preview
First page PDF preview